Skip to main content
. 2022 Aug 10;15:2303–2313. doi: 10.2147/JPR.S375257

Table 3.

Reduction of Medication Use >50% at Each Follow-Up Time Point

Total (n=117) Acute Zoster Group (n=36) Subacute Zoster Group (n=81) P
2 weeks after OP 48(41.0%) 17(47.2%) 31(38.3%) 0.364
1 month after OP 58(49.6%) 21(58.3%) 37(45.7%) 0.206
3 months after OP 66(56.4%) 24(66.7%) 42(51.9%) 0.136